Biotech "Tweets of the Week"
"Mini" Seen on the Stream
(December 14-18, 2015)
Looking for past biotech highlights? Check out the Biotech Tweets of the Week archive.
As seen on the stream...
FDA's Smith: "We know that many have looked at IMPROVE-IT it as a test of the LDL hypothesis. That is not on trial today"— Sue Sutter (@PinkSheetSutter) December 14, 2015
The FDA panel vote on Vytorin is a pretty stunning rebuke. I guess you can't believe what you read in @NEJM. $MRK @cardiobrief— Matthew Herper (@matthewherper) December 14, 2015
Valeant CEO Says Walgreens Deal ‘More Than Replaces Philidor’ $VRX— zach (@zbiotech) December 15, 2015
If Philidor was too small 2b "material",how come $VRX cut 4Q15 EPS guidance 37%? What a freaking joke. @WSJhealth— Roy Friedman (@DewDiligence) December 16, 2015
$CLVS gets 3-month delay in FDA decision for rociletinib; new pdufa June 28, 2016 https://t.co/Qj7bHIePwQ— Meg Tirrell (@megtirrell) December 15, 2015
New budget deal: -Delays Cadillac Tax 2 years -Pauses med. device tax 2 years -Pauses health ins. tax 1 year https://t.co/YU7pAMRa4I— Sarah Kliff (@sarahkliff) December 16, 2015
$GILD $GLPG Upfront $725M. Consisting of $300M licensing fee + $425M equity investment. Up to $1.35B in milestones + double-digit royalties— Bio Stocks™ (@BioStocks) December 17, 2015
Breaking: @MartinShkreli bond set at 6,667 Daraprim tablets $KBIO $RTRX— Red Acre Investments (@redacre) December 17, 2015
@matthewherper Levine’s column is and will be the best thing written about Martin’s indictment.— Adam Feuerstein (@adamfeuerstein) December 18, 2015
"We just cured hemophilia…I think I'll resign" - said nobody ever. $QURE— Brad Loncar (@bradloncar) December 18, 2015
Biomarin Says That FDA Has Advised it Will Not Take Action on the Kyndrisa (drisapersen) NDA by the PDUFA Date $BMRN https://t.co/NfVpcH4BjM— SAC Tracker (@FDAadcomm) December 18, 2015
$ISIS Isis Pharmaceuticals finally changes name after emergence of ISIS terror group. Now $IONS Ionis. https://t.co/wLeuzvd3Zg— Mandy Jackson (@ScripMandy) December 18, 2015